Sfoglia per Rivista I SUPPLEMENTI DI TUMORI
Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report
2014-01-01 Altavilla, A; Procopio, G; Alesini, D; Grillone, F; Massari, F; Zaniboni, A; Mattioli, R; Buti, S; Garanzini, E; Sisani, M; Hamzaj, A; Marrocolo, F; De Angelis, V; Bracarda, S
Erythrocyte mean corpuscolar volume change during pemetrexed chemotherapy in advanced non small cell lung cancer patients
2012-01-01 Bordi, P; Buti, S; Tiseo, M; Panni, S; Novello, S; Bria, E; Rapetti, S; Pilotto, S; Camisa, R; Ardizzoni, A
Multicenter experience of resected thymic epithelial tumors (TETs): an observational report on behalf of FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone)
2012-01-01 Genestreti, G; Burgio, Ma; Ampollini, Luca; Rolli, L; Sanna, S; Scarpi, E; Monti, M; Burgio, Sl; Giannone, L; Santo, A; Mezzetti, M; Gavelli, Giampaolo; Casanova, C; Buosi, R; Amadori, D.
Natural history of renal metastases to the pancreas: do not operate all and always?
2014-01-01 Burattini, L; Santoni, M; Conti, A; Partelli, S; Porta, C; Sternberg, Cn; Procopio, G; Bracarda, S; Basso, U; De Giorgi, U; Derosa, L; Rizzo, M; Ortega, C; Massari, F; Milella, M; Buti, S; Cerbone, L; Montironi, R; Falconi, M; Santini, D; Cascinu, S
Pemetrexed versus pemetrexed plus carboplatin in pretreated patients with advanced non-small cell lung cancer: a pooled analysis of two randomized trials
2011-01-01 Tiseo, M; Ardizzoni, A; Boni, L; Vincent, A; Buti, S; Camerini, A; Labianca, R; Genestreti, G; Zanelli, F; Ciuffreda, L; Di Costanzo, F; De Marinis, F; Crinò, L; Santo, A; Pazzola, A; Barbieri, F; Zilembo, N; Colantonio, I; Tibaldi, C; Smit, E on bealf of GOIRC and NVALT groups
Safety of targeted therapies (TTs) in metastatic renal cell carcinoma (mRCC) patients in haemodialysis (HD)
2013-01-01 Masini, C; Porta, C; Milella, M; Procopio, G; Di, Lorenzo G; Santoni, M; Buti, S; Iacovelli, R; Invernizzi, R; Moscetti, L; Aste, Mg; Pagano, M; Grosso, F; Manenti, Al; Ortega, C; Cosmai, L; Nicodemo, M; Donati, D; Del Giovane, C; Sabbatini, R
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report | 1-gen-2014 | Altavilla, A; Procopio, G; Alesini, D; Grillone, F; Massari, F; Zaniboni, A; Mattioli, R; Buti, S; Garanzini, E; Sisani, M; Hamzaj, A; Marrocolo, F; De Angelis, V; Bracarda, S | |
| Erythrocyte mean corpuscolar volume change during pemetrexed chemotherapy in advanced non small cell lung cancer patients | 1-gen-2012 | Bordi, P; Buti, S; Tiseo, M; Panni, S; Novello, S; Bria, E; Rapetti, S; Pilotto, S; Camisa, R; Ardizzoni, A | |
| Multicenter experience of resected thymic epithelial tumors (TETs): an observational report on behalf of FONICAP (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone) | 1-gen-2012 | Genestreti, G; Burgio, Ma; Ampollini, Luca; Rolli, L; Sanna, S; Scarpi, E; Monti, M; Burgio, Sl; Giannone, L; Santo, A; Mezzetti, M; Gavelli, Giampaolo; Casanova, C; Buosi, R; Amadori, D. | |
| Natural history of renal metastases to the pancreas: do not operate all and always? | 1-gen-2014 | Burattini, L; Santoni, M; Conti, A; Partelli, S; Porta, C; Sternberg, Cn; Procopio, G; Bracarda, S; Basso, U; De Giorgi, U; Derosa, L; Rizzo, M; Ortega, C; Massari, F; Milella, M; Buti, S; Cerbone, L; Montironi, R; Falconi, M; Santini, D; Cascinu, S | |
| Pemetrexed versus pemetrexed plus carboplatin in pretreated patients with advanced non-small cell lung cancer: a pooled analysis of two randomized trials | 1-gen-2011 | Tiseo, M; Ardizzoni, A; Boni, L; Vincent, A; Buti, S; Camerini, A; Labianca, R; Genestreti, G; Zanelli, F; Ciuffreda, L; Di Costanzo, F; De Marinis, F; Crinò, L; Santo, A; Pazzola, A; Barbieri, F; Zilembo, N; Colantonio, I; Tibaldi, C; Smit, E on bealf of GOIRC and NVALT groups | |
| Safety of targeted therapies (TTs) in metastatic renal cell carcinoma (mRCC) patients in haemodialysis (HD) | 1-gen-2013 | Masini, C; Porta, C; Milella, M; Procopio, G; Di, Lorenzo G; Santoni, M; Buti, S; Iacovelli, R; Invernizzi, R; Moscetti, L; Aste, Mg; Pagano, M; Grosso, F; Manenti, Al; Ortega, C; Cosmai, L; Nicodemo, M; Donati, D; Del Giovane, C; Sabbatini, R |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile